Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × CRC × spartalizumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 9 Stomach Neoplasms 8 Carcinoma, Hepatocellular 8 Neoplasm Metastasis 7 Triple Negative Breast Neoplasms 6 Rectal Neoplasms 6 Nasopharyngeal Carcinoma 6 Melanoma 6 Lymphoma, Extranodal NK-T-Cell 6 Colorectal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Locally Advanced Rectal Cancer 5 Carcinoma, Renal Cell 5 Sarcoma 4 Pancreatic Neoplasms 4 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Cholangiocarcinoma 3 Thyroid Neoplasms 2 Nasopharyngeal Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Kidney Neoplasms 2 Hemangiosarcoma 2 Gastrointestinal Stromal Tumors 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Turcot syndrome 1

Interventions

spartalizumab 1 pembrolizumab 1 Radiosurgery 1 Oncolytic Virotherapy 1 Leucovorin 1 Irinotecan 1 IFL protocol 1 HLX07 1 Fluorouracil 1 Drug Therapy 1 Cetuximab 1 CCT239065 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07381309 2026-02-02

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting

Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡